24th Jun 2015 06:46
LONDON (Alliance News) - Vectura Group PLC on Wednesday said it has appointed James Ward-Lilley as its chief executive officer and executive director.
Ward-Lilley will take over from Chris Blackwell, who it set to leave the business at the end of this month. Trevor Phillips will act as interim chief executive of Vectura until Ward-Lilley starts on October 1.
He will join the company, which makes products to treat airways-related diseases, from FTSE 100-listed pharmaceutical company AstraZeneca PLC, where is currently works as vice-president for its respiratory, inflammation and autoimmunity franchise.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
AstrazenecaVEC.L